Last reviewed · How we verify

NCT05202600

Justification of Incidental Appendectomy With Respect to Pathohistological Findings

Status unknown Last updated 21 January 2022
What this trial tests

trial testing Appendectomy in Appendix Tumor in 1,000 participants. Status unknown.

Timeline
1 February 2022
Primary endpoint
1 April 2022
1 June 2022

Quick facts

Lead sponsorUniversity Hospital of Split
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 February 2022
Primary completion1 April 2022
Estimated completion1 June 2022
Sites1 location across Croatia

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital of Split

Who can join

18 and older, any sex, with Appendix Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to justify performing an incidental appendectomy according to the following hypotheses: 1. The frequency of neoplasms in pathohistological (PHD) findings of incidental appendectomy (IA) is significantly higher than in PHD findings in appendectomies for acute appendcitis (AA) 2. The number needed to treat (NNT) for appendiceal tumors in the elderly is less than 500. 3. The rate of complicated AA in the elderly population is significantly higher than in the younger age group 4. NNT IA for complicated appendicitis in the elderly is less than 300. 5. NNT IA for potential death due to AA in the elderly is less than 500.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Appendectomy

Trials testing the same drug.

Other University Hospital of Split trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05202600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing